We are live on ! Find out more
NRC icon

NRC Health Common Stock

75 hedge funds and large institutions have $315M invested in NRC Health Common Stock in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 12

13% more capital invested

Capital invested by funds: $278M → $315M (+$37.1M)

2.79% more ownership

Funds ownership: 30.21%33% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less funds holding

Funds holding: 7875 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
75
Holders Change
-3
Holders Change %
-3.85%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
36
Reduced
12
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Kayne Anderson Rudnick Investment Management
1
Kayne Anderson Rudnick Investment Management
California
$118M +$17.6M +464,298 +18%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$28.2M +$316K +8,346 +1%
BlackRock
3
BlackRock
New York
$26.9M +$3.92M +103,348 +17%
CCA
4
Conestoga Capital Advisors
Pennsylvania
$22.2M +$3.21M +84,528 +17%
Vanguard Group
5
Vanguard Group
Pennsylvania
$19.2M +$472K +12,448 +3%
Renaissance Technologies
6
Renaissance Technologies
New York
$18.6M +$3.62M +95,500 +25%
SC
7
Spitfire Capital
California
$8.91M -$4.48M -118,047 -34%
RA
8
Royce & Associates
New York
$8.89M +$8.49K +224 +0.1%
State Street
9
State Street
Massachusetts
$7.55M +$656K +17,310 +10%
Northern Trust
10
Northern Trust
Illinois
$6.87M +$219K +5,788 +3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$5.35M +$1.13M +29,825 +27%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$5.01M +$111K +2,933 +2%
Morgan Stanley
13
Morgan Stanley
New York
$2.78M +$1.19M +31,286 +77%
Brown Advisory
14
Brown Advisory
Maryland
$2.66M
WIC
15
Willis Investment Counsel
Georgia
$2.63M +$118K +3,104 +5%
Charles Schwab
16
Charles Schwab
California
$2.29M +$107K +2,835 +5%
Ameriprise
17
Ameriprise
Minnesota
$2.21M +$249K +6,565 +13%
Comerica Bank
18
Comerica Bank
Texas
$2M
Bessemer Group
19
Bessemer Group
New Jersey
$1.83M
TCIM
20
TIAA CREF Investment Management
New York
$1.73M +$767K +20,229 +83%
OAM
21
Oxford Asset Management
United Kingdom
$1.46M +$302K +7,971 +27%
PAM
22
Panagora Asset Management
Massachusetts
$1.42M +$1.27M +33,375 +1,015%
Deutsche Bank
23
Deutsche Bank
Germany
$1.4M +$308K +8,129 +29%
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$1.34M -$42K -1,109 -3%
IP
25
Isthmus Partners
Wisconsin
$1.34M -$8.04K -212 -0.6%

NRC Hedge Fund Activity: Q3 2018 in Review

75 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q3 2018, worth a combined $315M — up 13% from $278M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of NRC and 7 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 36 added.

The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $17.6M. The largest seller was Spitfire Capital, cutting an estimated $4.48M.

  • 75 institutional investors held NRC Health Common Stock (NRC) as of Q3 2018, down from 78 in Q2 2018.
  • Funds reported $315M of NRC Health Common Stock stock for Q3 2018, up 13% quarter-over-quarter.
  • 7 funds opened new NRC Health Common Stock positions in Q3 2018 and 10 closed out, a net change of -3 holders.
  • The largest NRC Health Common Stock buyer in Q3 2018 was Kayne Anderson Rudnick Investment Management, an estimated $17.6M added.
  • The largest NRC Health Common Stock seller in Q3 2018 was Spitfire Capital, an estimated $4.48M sold.

Based on aggregated 13F filings for Q3 2018.